fibrinolysis plasmin tPA
Selected indexed studies
- Phenotypes of Disseminated Intravascular Coagulation. (Thromb Haemost, 2024) [PMID:37657485]
- A Narrative Review on Plasminogen Activator Inhibitor-1 and Its (Patho)Physiological Role: To Target or Not to Target? (Int J Mol Sci, 2021) [PMID:33800359]
- What drives "fibrinolysis"? (Hamostaseologie, 2015) [PMID:25564072]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- A Narrative Review on Plasminogen Activator Inhibitor-1 and Its (Patho)Physiological Role: To Target or Not to Target? (2021) pubmed
- Phenotypes of Disseminated Intravascular Coagulation. (2024) pubmed
- What drives "fibrinolysis"? (2015) pubmed
- The effect of plasmin-mediated degradation on fibrinolysis and tissue plasminogen activator diffusion. (2024) pubmed
- Fibrinolysis in a nutshell. (2025) pubmed
- Recombinant chymase inhibits fibrinolysis induced by endogenous plasmin in clotted human blood. (2025) pubmed
- Distinguishing Plasmin-Generating Microvesicles: Tiny Messengers Involved in Fibrinolysis and Proteolysis. (2023) pubmed
- Tissue plasminogen activator (tPA) inhibits plasmin degradation of fibrin. A mechanism that slows tPA-mediated fibrinolysis but does not require alpha 2-antiplasmin or leakage of intrinsic plasminogen. (1995) pubmed
- Fibrinolysis--a review. (1984) pubmed
- Fibrinolysis is impaired in patients with primary immune thrombocytopenia. (2024) pubmed